Dr. Reddy's Announces the Launch of Three Generic Drugs in the US
Indian pharmaceutical company, Dr. Reddy's Laboratories today announced the launch of three drugs in the US market. The two drugs are approved by the US drug regulator and are designed to treat central nervous system disorders.
The first drug launched by the company is Donepezil Hydrochloride, which is a recreation of Japan based Eisai Pharma's Aricept. The second drug released is Venlafaxine Hydrochloride, which is an imitator of Wyeth's Effexor XR. The drug is designed to treat depression and social anxiety.
Dr Reddy's drug Venlafaxine Hydrochloride will have to compete with bigger players of the market such as Mylan and Teva. The capsules of the new drug will be available in the market in 37.5mg, 75mg and 150mg strengths.
The sale of drug, Donepezil Hydrochloride in the US only, helped the company in gaining $ 2 billion for the financial year 2011. The drug is available in 5mg and 10mg strengths in 30, 90 and 500 count bottles.
After the announcement of the new drugs in the US, the shares of Reddy's laboratories' gained 1.66% during the day's trade on the Bombay Stock Exchange and were traded at Rs 1604.60.
New Zealand News
- Porsche reportedly developing electric version of 718 sports car
- Tesla Model Y Performance becomes little bit more expensive to order in China
- Porsche’s recently unveiled Mission R Concept previews electric race cars of future
- Chinese manufacturer GAC’s Aion V e-SUV can charge 0-80% in just 8 minutes
- Oshidori International exits Japanese casino race, citing serious ethical irregularities
- Italian motorcycle racer Valentino Rossi enters e-bike business with VR46 MTB range
- Micro Mobility shows off production version of Microlino 2.0 and 3-wheeled e-scooter
- Chinese electric motorcycle maker Evoke Motorcycles to set up shops in Spain
- TenneT adds more electric BMWs to study use of EVs to support power grids
- Italy’s ASPI announces plans to install cross-country ultra-fast EV charging network